3 min read Science Study finds 94 percent of patients with cancer respond well to COVID-19 vaccines: Small subsets of high-risk patients produce few or no antibodies, however 3 years ago In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines...